Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Curasan AG
  6. News
  7. Summary
    CURK   DE000A2YPGM4

CURASAN AG

(CURK)
SummaryChartsNewsRatingsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

curasan AG: Notification of a loss amounting to half of the equity capital in accordance with ž 92 (1) AktG

06/17/2020 | 10:50am EDT

DGAP-Ad-hoc: curasan AG / Key word(s): Miscellaneous
curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG

17-Jun-2020 / 16:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG


Kleinostheim, Germany, 17 June 2020 - The Management Board of curasan AG (shares: ISIN DE000A2YPGM4 / convertible bond: ISIN DE000A2TR497) hereby announces that it must be assumed at its best judgment that a loss of more than half of the share capital has occurred. This loss is mainly due to operating losses, aggravated by the corona pandemic.

In principle, a loss of half of the equity capital triggers a statutory obligation under Section 92 (1) of the German Stock Corporation Act (AktG) to invite shareholders to a general meeting without delay. Insolvency proceedings were opened for the assets of curasan AG with the resolution of 01 June 2020, Az. 651 IN 63/20.Due to the current insolvency proceedings, there is no need for a general meeting to be convened as a matter of principle pursuant to Section 92 (1) of the German Stock Corporation Act, which is why the issuer refrains from convening such a meeting.

Several investors have submitted indicative takeover bids, which are currently being negotiated. The business operations of the Issuer will continue in full as before.

---- End of the ad hoc release ----


Contact curasan AG:
Andrea Weidner
Investor Relations &
Corporate Communications
+49 6027 40 900-51
ir@curasan.com


 

17-Jun-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: curasan AG
Lindigstraße 4
63801 Kleinostheim
Germany
Phone: 06027/40 900 0
Fax: 06027/40 900 29
E-mail: info@curasan.de
Internet: www.curasan.de
ISIN: DE000A2YPGM4
WKN: A2YPGM
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1072609

 
End of Announcement DGAP News Service

1072609  17-Jun-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1072609&application_name=news&site_id=zonebourse

ę EQS 2020
All news about CURASAN AG
01/19CURASANá : Dirk Dembski new CEO at curasan AG
EQ
01/19PRESS RELEASE : Dirk Dembski new CEO at curasan AG
DJ
2020CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
2020CURASAN AG : curasan AG postpones annual financial report 2019 to 31 July 2020
EQ
2020CURASAN AG : Preliminary announcement of the publication of financial reports ac..
EQ
2020CURASAN AG : curasan AG and Donau Invest, Vienna, agree on a restructuring conce..
EQ
2020CURASAN AG : Notification of a loss amounting to half of the equity capital in a..
EQ
2020CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
2020CURASAN AG : Opening of insolvency proceedings on the assets of curasan AG
EQ
2020CURASAN AG : EBITDA 2019 probably better than results forecast
EQ
More news
Chart CURASAN AG
Duration : Period :
curasan AG Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Torben Sorensen Chief Executive Officer
Detlef Wilke Chairman-Supervisory Board
Fabian Peters Technical Director
Christine B÷hm Chief Medical Officer
Isabella de Krassny Member-Supervisory Board